Home›Stock Screener›Vaishali Pharma

Vaishali Pharma Share Price Today | Stock Price & Vaishali Pharma Share Screener

VAISHALI Pharmaceuticals
Live Share Price NSE
₹8.28
▼ -0.10 (-1.19%)
2026-10-05 00:00:00

As of October 5, 2026, the live Vaishali Pharma share price (NSE: VAISHALI) is ₹8.28, down 1.19% from the previous close, with shares trading between ₹8.22 and ₹8.95 in today's trading session, and a 52-week range of ₹4.88–₹10.26. Check VAISHALI price range for the annual price range and momentum. Use the Vaishali Pharma stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Vaishali Pharma opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Vaishali Pharma Market Cap ₹113.80 Cr.
VAISHALI P/E Ratio (TTM) 24.68
Vaishali Pharma P/B Ratio 1.58
EPS (TTM) ₹0.31
Dividend Yield -
Debt to Equity 0.24
VAISHALI 52 Week High ₹10.26
Vaishali Pharma 52 Week Low ₹4.88
Operating Margin -1.00%
Profit Margin -
VAISHALI Revenue (TTM) ₹28.00
EBITDA ₹1.00
Net Income -
Total Assets ₹123.00
Total Equity ₹69.00

Vaishali Pharma Share Price Chart

Track the current stock price of Vaishali Pharma with an interactive chart. Analyse VAISHALI share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Vaishali Pharma stock quote in one place.

The quote of ₹8.28 sits between the 52-week low of ₹4.88 and the 52-week high of ₹10.26, and the latest session moved -1.19% from the previous close.

Vaishali Pharma Company Profile - Fundamental Screener

Screen Vaishali Pharma company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for VAISHALI shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE972X01022.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E

Identifiers and Leadership

ISIN INE972X01022

Vaishali Pharma Balance Sheet Screener

Screen VAISHALI balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹123, up from ₹110 in 2025.

Latest statistics put total assets at ₹123 and shareholder funds at ₹69, with a leverage ratio of 0.24.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 123 110 80 79 82 86 66 69 64 45
Current Assets 113 105 75 73 76 81 61 63 59 40
Fixed Assets 2 2 2 2 1 1 2 1 1 1

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 6 5 4 6 3 4 4 5 3 4
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 69 65 43 41 26 22 21 21 21 4
Share Capital 26 26 11 11 11 11 11 7 7 3
Reserves & Surplus 43 39 32 30 16 12 11 15 14 1

Vaishali Pharma Income Statement Screener - Profit & Revenue Analysis

Screen Vaishali Pharma income statement and profit fundamentals. Analyze VAISHALI quarterly results. Vaishali Pharma reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Mar, revenue was ₹28 and net profit was ₹0, equal to earnings per unit of ₹0.03, at an operating margin of -1%.

In that period expenses were ₹27, interest cost ₹1 and tax ₹0. The next period listed, 2026-Jun, shows revenue of ₹24 and net profit of ₹2.

Item 2026-Mar 2026-Jun 2025-Jun 2025-Sept 2025-Dec

Revenue and Expenses

Revenue 28 24 25 34 26
Expenses 27 21 22 32 23

Operating Costs and Margins

EBITDA 1 2 2 2 2
Operating Profit % -1.00% 6.00% 6.00% 4.00% 6.00%
Depreciation 0 0 0 0 0
Interest 1 0 0 0 1

Profit and Earnings

Profit Before Tax 0 2 2 2 2
Tax 0 0 1 1 1
Net Profit 0 2 1 1 1
EPS 0.03 0.12 0.10 0.09 0.10

Vaishali Pharma Cash Flow Screener - Liquidity Fundamentals

Screen VAISHALI cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹0.

Over the same period, investing activities used ₹5 and financing activities provided ₹5.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities 0 -18 1 1 1 2 3 4 -10 1
Investing Activities -5 0 1 0 -1 0 0 0 1 1

Financing and Net Cash

Financing Activities 5 19 -1 -2 0 -2 -3 -4 9 -1
Net Cash Flow 0 0 1 0 1 0 0 0 0 0

Vaishali Pharma Shareholding Pattern Screener

See Vaishali Pharma shareholding pattern with promoter, FII, and DII holdings. Check Vaishali Pharma promoter holding and ownership changes for VAISHALI on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 31.61%, foreign institutions 0.00%, domestic institutions 0.00% and the public 62.32%, spread across 26,534 shareholders.

The shareholder count was 26,534 in 2026-Mar, compared with 26,671 in 2026-Jun.

Item 2026-Mar 2026-Jun 2026-Jul 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar

Promoter Holding

Promoter Holding 31.61% 31.61% 30.54% 26.32% 26.32% 26.32% 31.61% 26.32%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 62.32% 62.79% 60.70% 65.24% 65.88% 67.25% 62.75% 62.93%
Other Holding 6.07% 5.60% 8.76% 8.44% 7.80% 6.43% 5.65% 10.74%
Shareholder Count 26,534 26,671 26,697 28,874 28,682 27,752 27,752 9,390

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Vaishali Pharma. Vaishali Pharma dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Vaishali Pharma.

Vaishali Pharma Stock Index Membership - Nifty & Sensex

See which indices include Vaishali Pharma stock. Check VAISHALI index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Vaishali Pharma is not part of any tracked indices.
Only major market indices are tracked in our system.

Vaishali Pharma Market Events Screener - Corporate Actions

Get Vaishali Pharma corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Vaishali Pharma stock events that may affect VAISHALI share price, along with derivatives, futures and options activity and sector gainers.

12 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated August 14, 2026, with a record date of August 14, 2026.

It is followed by Quarterly Result Announcement dated May 30, 2026 and Quarterly Result Announcement dated February 13, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-08-14 2026-08-14 Quarterly Result Announcement NA 7.49%
2026-05-30 2026-05-30 Quarterly Result Announcement NA 0.71%
2026-02-13 2026-02-13 Quarterly Result Announcement NA 0.38%
2025-11-14 2025-11-14 Quarterly Result Announcement NA -1.85%
2025-08-11 2025-08-11 Quarterly Result Announcement NA -4.93%
2025-05-28 2025-05-28 Quarterly Result Announcement NA -1.61%
2025-02-06 2025-02-06 Quarterly Result Announcement NA 4.37%
2024-11-14 2024-11-14 Quarterly Result Announcement NA -8.12%
2024-10-15 2024-10-15 Split 2:10 19.65%
2024-10-15 2024-10-15 Bonus 1:1 -2.49%
2024-09-27 2024-09-27 Annual General Meeting NA 19.02%
2019-10-17 Bonus 3:5 -

Vaishali Pharma Competitors Screener - Peer Stocks Comparison

Screen VAISHALI competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 441,478 36.83 61,674 12.69% 11,565 47.42
Divis Laboratories 248,160 86.00 11,067 13.95% 2,568 58.71
Torrent Pharmaceuticals 182,729 86.72 13,886 20.34% 2,138 48.14
Zydus Life Science 116,030 25.96 27,658 17.64% 5,026 61.81
Cipla 109,788 33.29 29,045 2.24% 3,870 44.03
Laurus Labs 106,928 98.39 6,868 22.01% 890 58.00
Mankind Pharma 103,637 50.84 14,636 14.85% 1,938 64.24
Dr Reddys Laboratories 103,459 32.77 35,059 3.90% 4,158 69.59
Aurobindo Pharma 96,497 26.41 34,145 5.56% 3,503 54.69
Lupin 93,612 16.97 29,039 26.75% 5,356 34.02

Vaishali Pharma Company Announcements - News & Reports Screener

Screen VAISHALI latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated September 30, 2026.

The next most recent announcements are dated September 30, 2026 and September 4, 2026.

Date Update Actions
2026-09-30 Shareholders meeting -
2026-09-30 Shareholders meeting -
2026-09-04 General Updates -
2026-09-03 Copy of Newspaper Publication -
2026-09-01 Shareholders meeting -
2026-09-01 Record Date -
2026-09-01 General Updates -
2026-08-17 Copy of Newspaper Publication -
2026-08-14 Outcome of Board Meeting -
2026-08-14 Resignation of Director/KMP/SMP -
2026-08-14 Resignation of Director/KMP/SMP -
2026-08-14 Resignation of Director/KMP/SMP -
2026-08-14 Resignation -
2026-07-15 Certificate under SEBI (Depositories and Participants) Regulations, 2018 -
2026-07-09 Outcome of Board Meeting -
2026-07-04 Shareholders meeting -
2026-07-03 General Updates -
2026-07-03 Allotment of Securities -
2026-07-02 Outcome of Board Meeting -
2026-06-25 Trading Window -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹8.28, within a 52-week range of ₹4.88 to ₹10.26. The P/E ratio is 24.68 and the P/B ratio is 1.58, with earnings per unit of ₹0.31. Market capitalisation stands at ₹113.80 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 5 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.